Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-09

Clinical Trial Update: Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Diamyd administered into lymph nodes with vitamin D in type 1 diabetes has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diamyd
  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: Diamyd Medical AB | Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2023-01-09